Comparison Overview

Upstream

VS

Applied Clinical Trials Magazine

Upstream

125 Wood Street, London, undefined, EC2V 7AN, GB
Last Update: 2025-11-28

Upstream is the market-leading news source for the global oil and gas industry. We deliver news on the latest opportunities in oil, LNG and shale with focus on the key players, business, policy and trends. Our editorial strategy is to relentlessly pursue accurate, exclusive and independent news supported by insight, analysis, features and profiles - offering an insider’s view of the issues and the people impacting the sector.

NAICS: 511
NAICS Definition:
Employees: 55
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Applied Clinical Trials Magazine

undefined, Iselin, New Jersey, 08830, US
Last Update: 2025-11-26

Applied Clinical Trials magazine is the authoritative, peer-reviewed resource and thought leader for the global community that designs, initiates, manages, conducts, and monitors clinical trials. Industry professionals learn effective and efficient solutions to strategic and tactical challenges within the tightly regulated, highly competitive pharmaceutical environment. Our global, peer-reviewed journal's coverage features the process of managing clinical trials at the intersection where pharmaceutical product developers meet the strictly regulated medical researchers who test their new drugs.

NAICS: 511
NAICS Definition:
Employees: 3
Subsidiaries: 55
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/upstream-the-international-oil-&-gas-newspaper.jpeg
Upstream
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/applied-clinical-trials.jpeg
Applied Clinical Trials Magazine
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Upstream
100%
Compliance Rate
0/4 Standards Verified
Applied Clinical Trials Magazine
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Upstream in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Applied Clinical Trials Magazine in 2025.

Incident History — Upstream (X = Date, Y = Severity)

Upstream cyber incidents detection timeline including parent company and subsidiaries

Incident History — Applied Clinical Trials Magazine (X = Date, Y = Severity)

Applied Clinical Trials Magazine cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/upstream-the-international-oil-&-gas-newspaper.jpeg
Upstream
Incidents

No Incident

https://images.rankiteo.com/companyimages/applied-clinical-trials.jpeg
Applied Clinical Trials Magazine
Incidents

Date Detected: 08/2022
Type:Cyber Attack
Blog: Blog

Date Detected: 5/2018
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

Upstream company demonstrates a stronger AI Cybersecurity Score compared to Applied Clinical Trials Magazine company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Applied Clinical Trials Magazine company has historically faced a number of disclosed cyber incidents, whereas Upstream company has not reported any.

In the current year, Applied Clinical Trials Magazine company and Upstream company have not reported any cyber incidents.

Neither Applied Clinical Trials Magazine company nor Upstream company has reported experiencing a ransomware attack publicly.

Applied Clinical Trials Magazine company has disclosed at least one data breach, while Upstream company has not reported such incidents publicly.

Applied Clinical Trials Magazine company has reported targeted cyberattacks, while Upstream company has not reported such incidents publicly.

Neither Upstream company nor Applied Clinical Trials Magazine company has reported experiencing or disclosing vulnerabilities publicly.

Neither Upstream nor Applied Clinical Trials Magazine holds any compliance certifications.

Neither company holds any compliance certifications.

Applied Clinical Trials Magazine company has more subsidiaries worldwide compared to Upstream company.

Upstream company employs more people globally than Applied Clinical Trials Magazine company, reflecting its scale as a Book and Periodical Publishing.

Neither Upstream nor Applied Clinical Trials Magazine holds SOC 2 Type 1 certification.

Neither Upstream nor Applied Clinical Trials Magazine holds SOC 2 Type 2 certification.

Neither Upstream nor Applied Clinical Trials Magazine holds ISO 27001 certification.

Neither Upstream nor Applied Clinical Trials Magazine holds PCI DSS certification.

Neither Upstream nor Applied Clinical Trials Magazine holds HIPAA certification.

Neither Upstream nor Applied Clinical Trials Magazine holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.